1Zeng M S, Lid J, Liu Q L, et al. Genomic sequence analysis of Epstein- BarrVirus strain GDI form a nasopharyngeal carcinoma patient [J], J Vionl, 2005,79(24) : 15323-15330
2Khanna R, Busson P, Burrows SR, et al. Moulecular characterization of antigen-processing function in nasopharygeal carcinoma: evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cell[J], Cancer Res, 1998,58(2) :310- 314.
3Sbih-Lammali F, Clausse B, Ardila- Osorio H, et al. Control of apoptosis in Epstein -Barr virus -positive nasopharygeal carcinoma cell: opposite effects of CD95 and CD40 stimulation[J]. Cancer Res,1999,59 (4):924- 930.
4Nieland JD, Graus YF, Dortmans YF, et al. CD40 and CD70co-stimulate a potent in vivo antitumor T cell response [J]. J Immunother, 1998,21 (3) :225- 236.
5Rooney CM, Smith CA, Ng CYC, et al. Infusion of eytotoxiv T cells for the prevention and treatment of Epstein- Barr-virus-induced lymphoma in allogeneic transplant recipients[J]. Blood, 1998,92(5) : 1549-1555.
6Lawrences S, Young, Alan B, et al. Epstein-Barr Virus:40years [J]. Cancer, 2004,4(10) :757
7Alves G, Macrini CM, De Souza Nascimento P, et al. Detecton and espression of Epstine-Virus (EBV) DNA in tissues from penile tumours in Brazil [J]. cancer Lett,2004,215(1 ) :79-82.
8Lo S, Ho WK, Wei WI. Outcome of patients with positive Epstein-Barr virus serologic ststus in the absence of nasopharygeal carcinoma in Hong Kong [J]. Arch Otolaryngol Head Neck Surg,2004,130(6):770-772.
7[1]Lee AW,Poon YF,Foo W,et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treat during 1976～ 1985:overall survival and patterns of failure [J]. Int J Radiat Oncol Biol Phys,1992,23:261- 270.
8[2]Zeng Y,Zhong JM,Li LY,et al. Follow- up studies on Epstein- Barr virus IgA/VCA antibody positive persons in Zangwu country, China [J]. Intervirology,1983,20:190- 194.
